![Dr. Saul Rosenberg M.D., Hematologist (Blood Specialist)](/doctor_images/2/24/364014.jpg?v=cfa3)
Dr. Saul Rosenberg M.D.
Hematologist-Oncologist | Hematology & Oncology
269 Campus Dr Stanford CA, 94305About
Dr. Saul Rosenberg is a hematologist oncologist practicing in Stanford, CA. Dr. Rosenberg specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 1973
Provider Details
Fellowships
- Memorial Sloan - Kettering Cancer Center 1958
Publications
- ANLS OF ONCOLOGYEfficacy of abbreviated Stanford V chemotherapy2013
- JOURL OF CLINICAL ONCOLOGYRisk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma2013
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS2011
- LEUKEMIA & LYMPHOMARare presentation of classical Hodgkin lymphoma with a clol T2010
- ONCOLOGY RESEARCHDymic CD8 T-Cell Responses to Tumor2009
- JOURL OF CLINICAL ONCOLOGYLymphography: A Great Advance, Abandoned2008
- JOURL OF CLINICAL ONCOLOGYFollicular lymphoma revisited2008
- JOURL OF CLINICAL ONCOLOGYImpact of positive positron emission tomography on prediction of freedom from progression after2007
- ANLS OF HEMATOLOGYSplenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease2006
- JOURL OF CLINICAL ONCOLOGYStage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy2004
- JOURL OF CLINICAL ONCOLOGYStanford V and radiotherapy for locally extensive and advanced Hodgkin's disease2002
- ANLS OF ONCOLOGYTreatment of multicentric Castleman's disease complicated by the development of non1999
- JOURL OF CLINICAL ONCOLOGYStanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease1997
- BLOODComparison between conventiol salvage therapy1997
- ANLS OF ONCOLOGYThe magement of Hodgkin's disease: Half a century of change - The Kaplan Memorial Lecture1996
- JOURL OF CLINICAL ONCOLOGYBRIEF CHEMOTHERAPY, STANFORD-V1995
- Current opinion in oncologyModern combined modality magement of Hodgkin's disease.1994
- Anls of oncologyThe treatment of Hodgkin's disease.1994
- ANLS OF ONCOLOGYTHE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE1992
- EUROPEAN JOURL OF CANCERREDUCING THE TOXICITY OF THE COMBINED MODALITY THERAPY OF FAVORABLE STAGE HODGKINS-DISEASE1992
- JOURL OF CLINICAL ONCOLOGYPROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I1989
- JOURL OF CLINICAL ONCOLOGYVINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE1988
- ANLS OF INTERL MEDICINEINTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS1988
- JOURL OF CLINICAL ONCOLOGYEXPLORATORY LAPAROTOMY AND SPLENECTOMY FOR HODGKINS-DISEASE - A COMMENTARY1988
- BloodImprovements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades2013
- ANNALS OF ONCOLOGYEfficacy of abbreviated Stanford V chemotherapy2013
- JOURNAL OF CLINICAL ONCOLOGYRisk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma2013
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS2011
- LEUKEMIA & LYMPHOMARare presentation of classical Hodgkin lymphoma with a clonal T2010
- ONCOLOGY RESEARCHDynamic CD8 T-Cell Responses to Tumor2009
- JOURNAL OF CLINICAL ONCOLOGYLymphography: A Great Advance, Abandoned2008
- JOURNAL OF CLINICAL ONCOLOGYFollicular lymphoma revisited2008
- JOURNAL OF CLINICAL ONCOLOGYImpact of positive positron emission tomography on prediction of freedom from progression after2007
- ANNALS OF HEMATOLOGYSplenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease2006
- JOURNAL OF CLINICAL ONCOLOGYStage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy2004
- JOURNAL OF CLINICAL ONCOLOGYStanford V and radiotherapy for locally extensive and advanced Hodgkin's disease2002
- BLOODHigh-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first2001
- ANNALS OF ONCOLOGYTreatment of multicentric Castleman's disease complicated by the development of non1999
- JOURNAL OF CLINICAL ONCOLOGYStanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease1997
- BLOODComparison between conventional salvage therapy1997
- ANNALS OF ONCOLOGYThe management of Hodgkin's disease: Half a century of change - The Kaplan Memorial Lecture1996
- Horning, S. J., Rosenberg, S. A., Hoppe, R. T.Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease1996
- JOURNAL OF CLINICAL ONCOLOGYBRIEF CHEMOTHERAPY, STANFORD-V1995
- BLOODCLASSIFICATION OF LYMPHOID NEOPLASMS1994
- Current opinion in oncologyModern combined modality management of Hodgkin's disease.1994
- Annals of oncologyThe treatment of Hodgkin's disease.1994
- ANNALS OF ONCOLOGYTHE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE1992
- EUROPEAN JOURNAL OF CANCERREDUCING THE TOXICITY OF THE COMBINED MODALITY THERAPY OF FAVORABLE STAGE HODGKINS-DISEASE1992
- Rosenberg, S. A.THE CONTINUING CHALLENGE OF HODGKINS-DISEASE1991
- BLOODCEPP(B) - AN EFFECTIVE AND WELL-TOLERATED REGIMEN IN POOR-RISK, AGGRESSIVE NON-HODGKINS-LYMPHOMA1990
- CANCER RESEARCHHODGKINS-DISEASE - CHALLENGES FOR THE FUTURE1989
- JOURNAL OF CLINICAL ONCOLOGYPROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I1989
- Recent results in cancer research. Fortschritte der Krebsforschung. PrCurrent Stanford clinical trials for Hodgkin's disease.1989
- JOURNAL OF CLINICAL ONCOLOGYVINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE1988
- ANNALS OF INTERNAL MEDICINEINTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS1988
- JOURNAL OF CLINICAL ONCOLOGYEXPLORATORY LAPAROTOMY AND SPLENECTOMY FOR HODGKINS-DISEASE - A COMMENTARY1988
Dr. Saul Rosenberg M.D.'s Practice location
Practice At 269 Campus Dr
269 Campus Dr -Stanford, CA 94305Get Direction
Dr. Saul Rosenberg M.D.'s reviews
Write ReviewPatient Experience with Dr. Rosenberg
Recommended Articles
- Teen Finds Strength to Give Back After Battling Lymphoma
Ayden Mills is a 14-year-old middle school student residing in Vancouver, Washington. It’s easy to wonder how someone could be an inspiration at such a young age, but what Mills has gone fought through is nothing short of amazing. Mills’s story shows how it is possible to fight through even the...
- Facts About Multiple Myeloma
Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...
- John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society
Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
- Tips on How to Live with Multiple Myeloma
Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...
Nearby Providers
- Dr. Joseph Andrew Mollick M.D.875 Blake Wilbur Drive, Mc5820 Stanford CA 94305
- Dr. Wen-kai Weng M.D., PH.D.300 Pasteur Dr Stanford CA 94305
- Dr. David Bernard Miklos M.D., PH. D.300 Pasteur Dr Stanford CA 94305
- Dr. Alexander Dimitrios Colevas MD875 Blake Wilbur Drive Stanford CA 94305
- Dr. Arash Ash Alizadeh MD, PHD875 Blake Wilbur Drive Stanford CA 94305
- Dr. Hanlee P Ji M.D.875 Blake Wilbur Drive Stanford CA 94305
Nearest Hospitals
STANFORD HEALTH CAREl
300 PASTEUR DRIVE STANFORD CA 94305LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl
725 WELCH ROAD PALO ALTO CA 94304MENLO PARK SURGICAL HOSPITALl
570 WILLOW ROAD MENLO PARK CA 94025